Dr. Ralph Heaven, M.D.
What this data tells you about Dr. Heaven
Dr. Ralph Heaven is a medical oncology in Abilene, TX, with 19 years in practice. Based on federal Medicare data, Dr. Heaven performed 88,761 Medicare services across 4,132 unique beneficiaries.
Between the years covered by Open Payments, Dr. Heaven received a total of $3,158 from 28 pharmaceutical and/or device companies across 46 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Heaven is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 50,490 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 12,200 | $43 | $137 |
| Darbepoetin injection (Aranesp) for anemia | 7,188 | $2 | $20 |
| Contrast dye for imaging (iodine-based) | 7,075 | $0 | $3 |
| Paclitaxel chemotherapy injection | 2,319 | $0 | $8 |
| Blood draw (venipuncture) | 955 | $8 | $20 |
| Complete blood count (CBC) with differential | 801 | $8 | $36 |
| Dexamethasone injection (steroid) | 743 | $0 | $1 |
| Office visit, established patient (30-39 min) | 719 | $88 | $368 |
| Comprehensive metabolic blood panel | 706 | $10 | $64 |
| Injection, granisetron hydrochloride, 100 mcg | 480 | $0 | $24 |
| Lactate dehydrogenase (enzyme) level | 264 | $6 | $31 |
| Administration of chemotherapy into vein, 1 hour or less | 244 | $97 | $707 |
| Anti-nausea injection (Aloxi/palonosetron) | 210 | $1 | $114 |
| Carcinoembryonic antigen (cea) protein level | 167 | $19 | $99 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 162 | $47 | $313 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 159 | $22 | $157 |
| Blood creatinine level | 147 | $5 | $31 |
| Urea nitrogen level to assess kidney function, quantitative | 147 | $4 | $24 |
| Albumin (protein) level | 145 | $5 | $28 |
| Bilirubin level, total | 145 | $5 | $23 |
| Calcium level, total | 145 | $5 | $30 |
| Carbon dioxide (bicarbonate) level | 145 | $5 | $24 |
| Blood chloride level | 145 | $5 | $25 |
| Phosphatase (enzyme) level, alkaline | 145 | $5 | $27 |
| Blood potassium level | 145 | $5 | $30 |
| Liver enzyme (sgot), level | 145 | $5 | $33 |
| Liver enzyme (sgpt), level | 145 | $5 | $28 |
| Total protein level, blood | 142 | $4 | $42 |
| Microscopic examination for white blood cells with manual cell count | 135 | $4 | $22 |
| Complete blood count (CBC), automated | 135 | $6 | $34 |
| Drug injection, under skin or into muscle | 127 | $11 | $96 |
| Ferritin level test (iron stores) | 118 | $13 | $60 |
| Iron level test | 118 | $6 | $27 |
| Iron binding capacity test | 118 | $9 | $35 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 114 | $20 | $128 |
| Injection, zoledronic acid, 1 mg | 105 | $7 | $431 |
| Hospital follow-up visit, moderate complexity | 71 | $59 | $247 |
| PSA test (prostate cancer screening) | 69 | $18 | $94 |
| Office visit, established patient (20-29 min) | 65 | $66 | $250 |
| Reticulated (young) platelet measurement | 63 | $35 | $143 |
| Injection of additional new drug or substance into vein | 62 | $12 | $108 |
| Magnesium level test | 60 | $7 | $29 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 57 | $136 | $3,675 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 55 | $25 | $145 |
| Ct scan of chest with contrast | 54 | $48 | $821 |
| Irrigation of implanted venous access drug delivery device | 54 | $18 | $114 |
| Injection, diphenhydramine hcl, up to 50 mg | 48 | $1 | $7 |
| Infusion, normal saline solution , 1000 cc | 44 | $2 | $19 |
| Office visit, established patient, complex (40-54 min) | 42 | $128 | $496 |
| Administration of additional new drug or substance into vein, 1 hour or less | 41 | $49 | $344 |
| Administration of chemotherapy into vein, each additional hour | 39 | $21 | $161 |
| CT scan of abdomen and pelvis with contrast | 38 | $173 | $1,067 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 37 | $1,109 | $4,802 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 37 | $88 | $657 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 29 | $16 | $100 |
| Infusion into a vein for hydration, 31-60 minutes | 27 | $23 | $256 |
| Unclassified drugs | 22 | $1 | $8 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 21 | $350 | $1,722 |
| Hospital follow-up visit, high complexity | 19 | $91 | $357 |
| Drawing of blood for a medical problem | 18 | $59 | $264 |
| Ct scan of abdomen with contrast | 17 | $115 | $793 |
| Infusion into a vein for hydration, each additional hour | 17 | $10 | $75 |
| CT scan of chest, without contrast | 16 | $39 | $686 |
| Ct scan of abdomen and pelvis without contrast | 16 | $66 | $560 |
| Administration of additional new drug or substance into vein using push technique | 15 | $42 | $289 |
| New patient office visit, complex (60-74 min) | 15 | $168 | $709 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Heaven is a mixed practice specialist, with above-average Medicare volume (top 11% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Heaven experienced with iron infusion (feraheme)?
Does Dr. Heaven receive payments from pharmaceutical companies?
How do Dr. Heaven's costs compare to other medical oncologys in Abilene?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology